![Edita Mistiniene](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edita Mistiniene worked as Director of Research and Development at 3P Biopharmaceuticals SL from 2014 to 2017.
Prior to that, she was the Chief Scientist and Head of Research and Development at Teva Pharmaceutical Industries Ltd. Dr. Mistiniene received her graduate and doctorate degrees from Vilnius University.
| Unternehmen | Position | Ende |
|---|---|---|
3P Biopharmaceuticals SL
 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins and biological molecules | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2017 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Vilnius University
 Vilnius University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins and biological molecules | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
